Levosimendan - Bio-X ™

CAS: 141505-33-1

Ref. 3D-BM164625

Produktinformation

• Name: Levosimendan - Bio-X ™
• Synonyme: [[4-[(4R)-1,4,5,6-Terahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]propanedinitrile(R)-SimendanOR-1259Mesoxalonitrile (-)- {p-[(R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl}hydrazone

Beschreibung

Levosimendan has been shown to act as a calcium sensitiser and increase cytosolic Ca2+ levels. It is an analog of the cardiac glycoside, ouabain. This drug has been shown to be effective for the treatment of congestive heart failure and is used to increase the heart’s contractility and decrease its rate in patients who have low cardiac output. Levosimendan also causes vasodilation by increasing nitric oxide production in vascular endothelial cells.

Levosimendan is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 280.28 g/mol
• Formel: C₁₄H₁₂N₆O
• Reinheit: Min. 95%
• Farbe/Form: Powder